medigraphic.com

2018, Number 1

<< Back Next >>

Rev Mex Med Repro 2018; 8.9 (1)

Implantation failure: mother or embryo

Raphael Obiala E

Language: Spanish
References: 38
Page: 5-16
PDF size: 350.74 Kb.


ABSTRACT

The success of assisted reproductive technologies has been increasing since the birth of the first test-tube baby. Nowadays, however, there are a number of factors that remain to be clarified, such as: the influence of the integrity of male gametes and females in fertilization, the development of the embryo, as well as the influence of controlled ovarian hyperstimulation, markers of endometrial receptivity, uterine abnormalities and immunological factors that affect genetic and molecular expression. A better understanding of these mechanisms will allow us to increase the rate of implantation, clinical pregnancies and births of healthy babies, in patients subjected to assisted reproduction techniques. This paper describes the factors involved of the mother or the embryo in the implantation failure and which of these are seen more frequently. There are different factors that favor the occurrence of a failure in the implantation, some articles mention that it may be due to embryonic, uterine or systemic causes.


REFERENCES

  1. Palma C, Ignacio VB. Infertilidad masculina, Rev Med Clin Condes 2014;25(1):122-128, Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_ f=10&pident_articulo=90360739&pident_ usuario=0&pcontactid=&pident_revista=202&ty=64&acc ion=L&origen=zonadelectura&web=www.elsevier.es&lan =es&fichero=202v25n01a90360739pdf001.pdf

  2. Vázquez ML. Infertilidad, Manual para el consultorio. FESGO. 1a ed. México: Nieto editores, 2011;1- 6.

  3. Stahl P, Stember D, Goldstein M. Annu Rev Med 2012;63:525-540.

  4. World Health Organization. WHO Laboratory Manual for the examination and processing of human semen. Cambridge: Cambridge University. 5th ed. 2010. http://whqlibdoc. who.int/publications/ 2010/9789241547789_eng.pdf

  5. Colegio de ginecología de México, Evaluación, diagnóstico y tratamiento del varón infértil. Ginecol Obstet Mex 2011;79(11):746-753.

  6. French DB, Sabanegh ES Jr, Goldfarb J, et al. Does severe teratozoospermia affect blastocyst formation, live birth rate, and other clinical outcome parameters in ICSI cycles? Fertil Steril 2010;93:1097-103.

  7. Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights into mechanisms behind miscarriage. BMC medicine 2013;11(1):154.

  8. Dohle GR, Diemer T, Giwercman A, Jungwirth A, et al. Guía clínica sobre la infertilidad masculina, European Association of Urology 2010;902-978, disponible en: http://uroweb.org/wp-content/uploads/13-GUIA-CLINICASOBRE- INFERTILIDAD-MASCULINA.pdf

  9. Robbins J, Broadwell C, Chow L, Parry J, Sadowski E. Alterations of the Mullerian ducts: embryology development, classification and evaluation of MRI. 2014.

  10. Reichman DE, Laufer MR. Congenital uterine anomalies affecting reproduction. Best Practice & Research Clinical Obstetrics & Gynaecology 2010;24(2):93-208.

  11. Hua M, Odibo AO, Longman RE, Macones GA, et al. Congenital uterine anomalies and adverse pregnancy outcomes. Am J Obstet Gynecol 2011;205(6):558-e1.

  12. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assisted Reprod Gen 2012;29(11):1227-1239.

  13. Sun Y, Fang L, Su Y, Guo Y. Uterine cavity shape and the best site for embryo transfer. Int J Gynecol Obstet 2009;105(2):140-144.

  14. Szmelskyj I, Aquilina L, Szmelskyj. Acupuncture for IVF and assisted reproduction. An integrated approach to treatment and management. 2015;301-338. [Versión de Elsevier]. doi: 10.1016 / B978-0-7020-5010-7.00012-6

  15. Xu B, Sun X, Li L, Wu L, Zhang A, Feng Y. Pinopodes, leukemia inhibitory factor, integrin-β3, and mucin-1 expression in the peri-implantation endometrium of women with unexplained recurrent pregnancy loss. Fertil Steril 2012;98(2):389-395.

  16. Ginecología y Obstetricia de México, Diagnóstico y tratamiento del factor tuboperitoneal. Ginecol Obstet Mex 2011;79(11):725-731. Disponible en: http://www.medigraphic. com/pdfs/ginobsmex/gom-2011/gom1111h.pdf

  17. Senapati S, Barnhart K. Managing endometriosis associated infertility. Clin Obstet Gynecol 2011;54(4):720.

  18. DeCherney AH, Nathan L, Laufer N, Roman AS. Current Diagnosis & Treatment Obstetrics & Gynecology. 11th ed. 2012.

  19. Szczepańska M, Wirstlein P, Łuczak M, Jagodziński PP, Skrzypczak J. Reduced expression of HOXA10 in the midluteal endometrium from infertile women with minimal endometriosis. Biomedicine & Pharmacotherapy 2010;64(10):697-705.

  20. Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis- induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril 2010;94(5):1894-1899.

  21. Cunningham F, Leveno K, Bloom S, et al. Williams Obstetrics. McGraw-Hill Professional, 2014.

  22. Gutiérrez A, Vidal A. HYPERLINK MJ de los Santos JJ, Tarín J, Remohí A, Pellicer. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Human Reproduction 1994;9(4):725-729.

  23. Brunicardi F, Andersen D, Billiar T, Dunn D, et al. Principios de Schwartz de Cirugía. McGraw-Hill Education, 2014.

  24. Ben-Nagi J, Miell J, Mavrelos D, Naftalin J, et al. Endometrial implantation factors in women with submucous uterine fibroids. Reproductive biomedicine online 2010;21(5):610- 615.

  25. Eldar-Geva T, Meagher S, Healy DL, MacLachlan V, et al. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril 1998;70(4):687-691.

  26. Kitaya K, Yasuo T. Leukocyte density and composition in human cycling endometrium with uterine fibroids. Human Immunology 2010;71(2):158-163.

  27. Pérez-López FR, Ornat L, Ceausu I, Depypere H, et al. EMAS position statement: Management of uterine fibroids. Maturitas 2014;79(1):106-116.

  28. Robertson SA, Petroff MG, Hunt JS. Immunology of pregnancy. Australia. USA. 2015;Volume 2:1835-1874.

  29. Tilburgs T, Scherjon SA, Claas FH. Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal–maternal interface. J Reprod Immunol 2010;85(1):58-62.

  30. Fettke F, Schumacher A, Costa SD, Zenclussen AC. B cells: the old new players in reproductive immunology. Name: Frontiers in Immunology 2014;5:285.

  31. Vázquez-Rodríguez S, Bouchan-Valencia P, González- Jiménez MA, Paredes-Vivas LY, Calixto-González R, Cérbulo- Vázquez A. Mecanismos de tolerancia inmunológica en el embarazo. Perinatol Reprod Hum 2011;25(1):39-45.

  32. Valdés A, Pérez Núñez HM, García Rodríguez RE, López Gutiérrez A. Embriología humana. Cuba. Editorial Ciencias Médicas. 2010.

  33. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assisted Reprod Gen 2012;29(11):1227-1239.

  34. Tremellen KP, Russell P. The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages. J Reprod Immunol 2012;93(1):58-63.

  35. Xiao Y, Li T, Xia E, Yang X, et al. Expression of integrin β3 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window. Eur J Obstet Gynecol Reprod Biol 2013;170(2):419-422.

  36. Gonella Á, Grajales H, Hernández A. Receptive uterine environment: maternal control, control embryo, embryonic death. Revista MVZ Córdoba 2010;15(1):1976-1984.

  37. Paria BC, Song H, Dey SK. Implantation: molecular basis of embryo-uterine dialogue. Int J Develop Biol 2001;45(3):597-606.

  38. Young SL. Oestrogen and progesterone action on endometrium: a translational approach to understanding endometrial receptivity. Reprod Biomed Online 2013;27(5):497-505.




2020     |     www.medigraphic.com